Abingdon Health PLC ABDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX8.50
- Day Range
- GBX8.00–9.00
- 52-Week Range
- GBX5.50–13.00
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 435.07M
- Market Cap
- GBX3.70B
- Volume/Avg
- 32,459 / 99,736
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. The Company operates in the UK, USA/Canada, Europe, and rest of world.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 131
Valuation
Metric | ABDX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.34 |
Price/Sales | 3.20 |
Price/Cash Flow | — |
Price/Earnings
ABDX
Financial Strength
Metric | ABDX |
|---|---|
Quick Ratio | 1.71 |
Current Ratio | 1.91 |
Interest Coverage | −44.78 |
Quick Ratio
ABDX
Profitability
Metric | ABDX |
|---|---|
Return on Assets (Normalized) | −14.91% |
Return on Equity (Normalized) | −27.69% |
Return on Invested Capital (Normalized) | −21.69% |
Return on Assets
ABDX
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|J&tf&Q>> | LOCK|M@ | $248B | |||
| Danaher Corp DHR | LOCK|CH?dD?&$ | LOCK|fg | $155B | |||
| IDEXX Laboratories Inc IDXX | LOCK|CCNZGv> | LOCK|$xJ | $53B | |||
| Agilent Technologies Inc A | LOCK|#@^!Vkr | LOCK|#V | $48B | |||
| Waters Corp WAT | LOCK|<%$y%B | LOCK|H# | $43B | |||
| IQVIA Holdings Inc IQV | LOCK|%b#!M< | LOCK|c$#&# | $41B | |||
| Mettler-Toledo International Inc MTD | LOCK|<gqc<Vh | LOCK|JCW<$ | $33B | |||
| Labcorp Holdings Inc LH | LOCK|hL!Q@?l& | LOCK|@!$F% | $30B | |||
| Illumina Inc ILMN | LOCK|%nl?$X | LOCK|&M#rP | $29B | |||
| Quest Diagnostics Inc DGX | LOCK|q$%>>s | LOCK|g>Pbp | $28B |